SG Americas Securities
CLB icon

SG Americas Securities’s Core Laboratories CLB Stock Holding History

SG Americas Securities’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Sell
11,652
-199
-2% -$2.84K ﹤0.01% 2969
2026
Q1 		$199K Sell
11,851
-4,674
-28% -$83.6K ﹤0.01% 2638
2025
Q4 		$265K Buy
+16,525
New +$246K ﹤0.01% 2816
2025
Q3 		– Sell
-8,907
Closed -$103K – 3404
2025
Q2 		$103K Sell
8,907
-8,297
-48% -$98.4K ﹤0.01% 2621
2025
Q1 		$258K Sell
17,204
-6,519
-27% -$109K ﹤0.01% 2338
2024
Q4 		$411K Sell
23,723
-46,017
-66% -$888K ﹤0.01% 1511
2024
Q3 		$1.29M Buy
69,740
+45,232
+185% +$908K ﹤0.01% 891
2024
Q2 		$497K Buy
24,508
+14,158
+137% +$251K ﹤0.01% 1684
2024
Q1 		$177K Sell
10,350
-11,649
-53% -$183K ﹤0.01% 2064
2023
Q4 		$389K Buy
21,999
+151
+0.7% +$3.04K ﹤0.01% 1640
2023
Q3 		$525K Buy
+21,848
New +$536K 0.01% 1737
2023
Q2 		– Sell
-6,429
Closed -$142K – 2420
2023
Q1 		$142K Buy
+6,429
New +$150K ﹤0.01% 2678
2022
Q2 		– Sell
-20,520
Closed -$649K – 3435
2022
Q1 		$649K Sell
20,520
-8,006
-28% -$224K ﹤0.01% 1721
2021
Q4 		$636K Buy
28,526
+4,750
+20% +$124K ﹤0.01% 1982
2021
Q3 		$660K Buy
+23,776
New +$724K ﹤0.01% 2269
2020
Q1 		– Sell
-3,821
Closed -$144K – 3463
2019
Q4 		$144K Sell
3,821
-10,889
-74% -$489K ﹤0.01% 2718
2019
Q3 		$686K Sell
14,710
-4,565
-24% -$212K 0.01% 1674
2019
Q2 		$1.01M Buy
19,275
+15,382
+395% +$902K 0.01% 1422
2019
Q1 		$268K Sell
3,893
-1,674
-30% -$112K ﹤0.01% 2353
2018
Q4 		$332K Sell
5,567
-13,269
-70% -$1.15M ﹤0.01% 2107
2018
Q3 		$2.18M Buy
18,836
+11,204
+147% +$1.26M 0.02% 1101
2018
Q2 		$963K Buy
7,632
+1,078
+16% +$131K 0.01% 1470
2018
Q1 		$709K Sell
6,554
-7,234
-52% -$801K 0.01% 1618
2017
Q4 		$1.51M Buy
13,788
+9,545
+225% +$953K 0.01% 1071
2017
Q3 		$419K Buy
4,243
+2,120
+100% +$206K ﹤0.01% 1989
2017
Q2 		$215K Sell
2,123
-2,271
-52% -$245K ﹤0.01% 2376
2017
Q1 		$508K Sell
4,394
-2,786
-39% -$324K ﹤0.01% 1842
2016
Q4 		$862K Buy
7,180
+5,066
+240% +$561K 0.01% 1387
2016
Q3 		$237K Sell
2,114
-1,387
-40% -$160K ﹤0.01% 2344
2016
Q2 		$434K Sell
3,501
-8,303
-70% -$1M ﹤0.01% 1779
2016
Q1 		$1.33M Buy
11,804
+2,526
+27% +$262K 0.01% 1133
2015
Q4 		$1.01M Buy
+9,278
New +$1.06M 0.01% 1137
2015
Q2 		– Sell
-1,684
Closed -$176K – 2632
2015
Q1 		$176K Sell
1,684
-1,044
-38% -$111K ﹤0.01% 1950
2014
Q4 		$328K Buy
+2,728
New +$358K ﹤0.01% 1987
2014
Q3 		– Sell
-1,350
Closed -$226K – 2658
2014
Q2 		$226K Sell
1,350
-3,037
-69% -$540K ﹤0.01% 1980
2014
Q1 		$871K Buy
4,387
+1,846
+73% +$348K ﹤0.01% 1201
2013
Q4 		$485K Sell
2,541
-784
-24% -$146K ﹤0.01% 1573
2013
Q3 		$563K Buy
3,325
+1,353
+69% +$210K ﹤0.01% 1547
2013
Q2 		$299K Buy
+1,972
New +$279K ﹤0.01% 1518

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SG Americas Securities's CLB Position: Q2 2026 in Review

SG Americas Securities reduced its Core Laboratories (CLB) stake by 1.7% in Q2 2026, selling an estimated $2.84K and leaving 11,652 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

SG Americas Securities first reported a position in CLB in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.18M in Q3 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • SG Americas Securities held 11,652 shares of Core Laboratories worth $136K as of Q2 2026.
  • SG Americas Securities sold 199 Core Laboratories shares in Q2 2026, an estimated $2.84K.
  • Core Laboratories made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2969 holding.
  • SG Americas Securities first reported a position in Core Laboratories in Q2 2013 and has held it in 39 quarters since.
  • SG Americas Securities's Core Laboratories position peaked at $2.18M in Q3 2018.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.